25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

VBS (Vectus Biosystems Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Vectus Biosystems Ltd together

I guess you are interested in Vectus Biosystems Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Vectus Biosystems Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Vectus Biosystems Ltd’s Price Targets

I'm going to help you getting a better view of Vectus Biosystems Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vectus Biosystems Ltd

I send you an email if I find something interesting about Vectus Biosystems Ltd.

1. Quick Overview

1.1. Quick analysis of Vectus Biosystems Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Vectus Biosystems Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.14
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.13
Return On Investment
-76.9%

For what price can you sell your share?

Current Price per Share
A$0.17
Expected price per share
A$0.095 - A$0.235
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vectus Biosystems Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.17
Intrinsic Value Per Share
A$-0.30 - A$0.74
Total Value Per Share
A$-0.31 - A$0.73

2.2. Growth of Vectus Biosystems Ltd (5 min.)




Is Vectus Biosystems Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?-$167.2k$968.5k-$1.1m-679.2%

How much money is Vectus Biosystems Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.1m-$1.5m$365.4k31.6%
Net Profit Margin-371.7%-205.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Vectus Biosystems Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#723 / 849

Most Revenue
#534 / 849

Most Profit
#257 / 849

Most Efficient
#550 / 849
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vectus Biosystems Ltd?

Welcome investor! Vectus Biosystems Ltd's management wants to use your money to grow the business. In return you get a share of Vectus Biosystems Ltd.

First you should know what it really means to hold a share of Vectus Biosystems Ltd. And how you can make/lose money.

Speculation

The Price per Share of Vectus Biosystems Ltd is A$0.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vectus Biosystems Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vectus Biosystems Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vectus Biosystems Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.02-12.8%-0.02-12.8%-0.03-16.8%-0.03-18.1%-0.04-22.8%-0.04-21.6%
Usd Book Value Change Per Share-0.02-12.5%-0.02-12.5%-0.02-14.6%0.0210.0%0.029.3%-0.01-8.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.029.7%0.0420.7%0.0318.6%
Usd Total Gains Per Share-0.02-12.5%-0.02-12.5%-0.02-14.6%0.0319.6%0.0530.0%0.0210.3%
Usd Price Per Share0.03-0.03-0.05-0.12-0.38-0.49-
Price to Earnings Ratio-1.20--1.20--1.76--3.25--7.95--12.37-
Price-to-Total Gains Ratio-1.22--1.22--2.02--0.43-5.26--4.08-
Price to Book Ratio-8.31--8.31-2.76-0.37--7.12-59.36-
Price-to-Total Gains Ratio-1.22--1.22--2.02--0.43-5.26--4.08-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.110772
Number of shares9027
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.04
Usd Book Value Change Per Share-0.020.02
Usd Total Gains Per Share-0.020.05
Gains per Quarter (9027 shares)-192.23459.67
Gains per Year (9027 shares)-768.921,838.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-769-77912695691829
20-1538-1548253911393668
30-2307-2317380817085507
40-3076-3086507722787346
50-3845-3855634628479185
60-4614-46247616341711024
70-5382-53938885398612863
80-6151-616210154455514702
90-6920-693111423512516541
100-7689-770012693569418380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.014.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%2.08.00.020.0%4.010.00.028.6%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%5.00.05.050.0%5.00.09.035.7%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%6.08.00.042.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vectus Biosystems Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.033-0.0330%-0.038+17%0.026-226%0.024-235%-0.022-34%
Book Value Per Share---0.005-0.0050%0.028-117%0.030-116%-0.010+100%-0.021+344%
Current Ratio--0.9310.9310%3.448-73%2.840-67%2.639-65%2.155-57%
Debt To Asset Ratio--1.3281.3280%0.266+399%0.611+117%1.074+24%4.236-69%
Debt To Equity Ratio----0%0.363-100%0.226-100%0.135-100%0.611-100%
Dividend Per Share----0%-0%0.025-100%0.054-100%0.048-100%
Enterprise Value--1345043.2401345043.2400%4376373.487-69%10344182.122-87%28877861.250-95%38360412.502-96%
Eps---0.033-0.0330%-0.044+32%-0.047+42%-0.059+78%-0.056+69%
Ev To Ebitda Ratio---0.797-0.7970%-1.927+142%-3.554+346%-8.568+975%-10.672+1239%
Ev To Sales Ratio--2.8132.8130%3.843-27%8.447-67%75456.307-100%46869.776-100%
Free Cash Flow Per Share---0.016-0.0160%-0.039+153%-0.033+113%-0.049+214%-0.047+202%
Free Cash Flow To Equity Per Share---0.012-0.0120%-0.040+225%-0.007-43%-0.010-23%-0.004-66%
Gross Profit Margin--1.3091.3090%1.634-20%1.474-11%1.411-7%1.437-9%
Intrinsic Value_10Y_max--0.735----------
Intrinsic Value_10Y_min---0.302----------
Intrinsic Value_1Y_max---0.010----------
Intrinsic Value_1Y_min---0.045----------
Intrinsic Value_3Y_max--0.033----------
Intrinsic Value_3Y_min---0.122----------
Intrinsic Value_5Y_max--0.154----------
Intrinsic Value_5Y_min---0.187----------
Market Cap9066666.270+76%2133333.2402133333.2400%4106666.487-48%9902221.789-78%30847998.650-93%40330664.902-95%
Net Profit Margin---3.717-3.7170%-2.053-45%-2.772-25%-4292.549+115394%-3031.292+81459%
Operating Margin---3.558-3.5580%-2.046-43%-2.664-25%-4139.194+116231%-3387.036+95092%
Operating Ratio--4.5294.5290%3.046+49%3.657+24%3080.389-100%2858.209-100%
Pb Ratio-35.331-325%-8.313-8.3130%2.763-401%0.370-2347%-7.121-14%59.364-114%
Pe Ratio-5.101-325%-1.200-1.2000%-1.756+46%-3.254+171%-7.945+562%-12.369+930%
Price Per Share0.170+76%0.0400.0400%0.077-48%0.186-78%0.578-93%0.756-95%
Price To Free Cash Flow Ratio-10.923-325%-2.570-2.5700%-1.955-24%-4.809+87%-9.663+276%-15.714+511%
Price To Total Gains Ratio-5.202-325%-1.224-1.2240%-2.016+65%-0.427-65%5.257-123%-4.085+234%
Quick Ratio--0.8240.8240%3.339-75%2.746-70%2.448-66%2.477-67%
Return On Assets---2.271-2.2710%-1.154-49%-1.390-39%-1.148-49%-3.409+50%
Return On Equity----0%-1.5730%-0.8510%-0.5100%-3.5960%
Total Gains Per Share---0.033-0.0330%-0.038+17%0.051-164%0.078-142%0.027-221%
Usd Book Value---167214.895-167214.8950%968515.434-117%1032405.248-116%-334603.377+100%-742748.805+344%
Usd Book Value Change Per Share---0.021-0.0210%-0.025+17%0.017-226%0.016-235%-0.014-34%
Usd Book Value Per Share---0.003-0.0030%0.018-117%0.019-116%-0.006+100%-0.014+344%
Usd Dividend Per Share----0%-0%0.016-100%0.035-100%0.032-100%
Usd Enterprise Value--876430.175876430.1750%2851644.964-69%6740269.071-87%18816814.391-95%24995644.786-96%
Usd Eps---0.022-0.0220%-0.029+32%-0.031+42%-0.039+78%-0.037+69%
Usd Free Cash Flow---540885.341-540885.3410%-1368820.030+153%-1151304.004+113%-1696561.407+214%-1633732.375+202%
Usd Free Cash Flow Per Share---0.010-0.0100%-0.026+153%-0.022+113%-0.032+214%-0.031+202%
Usd Free Cash Flow To Equity Per Share---0.008-0.0080%-0.026+225%-0.005-43%-0.006-23%-0.003-66%
Usd Market Cap5907839.742+76%1390079.9391390079.9390%2675903.883-48%6452287.718-78%20100555.921-93%26279461.250-95%
Usd Price Per Share0.111+76%0.0260.0260%0.050-48%0.121-78%0.377-93%0.493-95%
Usd Profit---1158061.964-1158061.9640%-1523521.598+32%-1642953.580+42%-2009438.224+74%-1929007.261+67%
Usd Revenue--311583.391311583.3910%741959.978-58%645386.125-52%556681.689-44%289915.606+7%
Usd Total Gains Per Share---0.021-0.0210%-0.025+17%0.033-164%0.051-142%0.018-221%
 EOD+6 -2MRQTTM+0 -0YOY+18 -193Y+10 -295Y+16 -2310Y+20 -19

3.3 Fundamental Score

Let's check the fundamental score of Vectus Biosystems Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.101
Price to Book Ratio (EOD)Between0-1-35.331
Net Profit Margin (MRQ)Greater than0-3.717
Operating Margin (MRQ)Greater than0-3.558
Quick Ratio (MRQ)Greater than10.824
Current Ratio (MRQ)Greater than10.931
Debt to Asset Ratio (MRQ)Less than11.328
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.271
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Vectus Biosystems Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5096.059
Ma 20Greater thanMa 500.080
Ma 50Greater thanMa 1000.073
Ma 100Greater thanMa 2000.061
OpenGreater thanClose0.155
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Vectus Biosystems Ltd

Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for cardiovascular fibrosis and systolic blood pressure, as well as treatments for cardiac fibrosis, kidney, liver, and lung fibrosis. Its lead compound is VB0004, currently under phase Ib clinical human trial, which is aimed at treating the loss of functional tissue to fibrosis, and scarring. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. The company was incorporated in 2005 and is based in Rosebery, Australia.

Fundamental data was last updated by Penke on 2025-10-09 09:52:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Vectus Biosystems Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -371.7% means that $-3.72 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vectus Biosystems Ltd:

  • The MRQ is -371.7%. The company is making a huge loss. -2
  • The TTM is -371.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-371.7%TTM-371.7%0.0%
TTM-371.7%YOY-205.3%-166.3%
TTM-371.7%5Y-429,254.9%+428,883.2%
5Y-429,254.9%10Y-303,129.2%-126,125.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-371.7%-77.6%-294.1%
TTM-371.7%-167.4%-204.3%
YOY-205.3%-186.4%-18.9%
3Y-277.2%-263.9%-13.3%
5Y-429,254.9%-345.5%-428,909.4%
10Y-303,129.2%-477.5%-302,651.7%
4.3.1.2. Return on Assets

Shows how efficient Vectus Biosystems Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • -227.1% Return on Assets means that Vectus Biosystems Ltd generated $-2.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vectus Biosystems Ltd:

  • The MRQ is -227.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -227.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-227.1%TTM-227.1%0.0%
TTM-227.1%YOY-115.4%-111.7%
TTM-227.1%5Y-114.8%-112.3%
5Y-114.8%10Y-340.9%+226.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-227.1%-12.0%-215.1%
TTM-227.1%-11.9%-215.2%
YOY-115.4%-11.0%-104.4%
3Y-139.0%-12.0%-127.0%
5Y-114.8%-11.7%-103.1%
10Y-340.9%-13.8%-327.1%
4.3.1.3. Return on Equity

Shows how efficient Vectus Biosystems Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • 0.0% Return on Equity means Vectus Biosystems Ltd generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vectus Biosystems Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-157.3%+157.3%
TTM-5Y-51.0%+51.0%
5Y-51.0%10Y-359.6%+308.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.2%+14.2%
TTM--14.8%+14.8%
YOY-157.3%-15.0%-142.3%
3Y-85.1%-16.6%-68.5%
5Y-51.0%-16.9%-34.1%
10Y-359.6%-19.5%-340.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vectus Biosystems Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Vectus Biosystems Ltd is operating .

  • Measures how much profit Vectus Biosystems Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • An Operating Margin of -355.8% means the company generated $-3.56  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vectus Biosystems Ltd:

  • The MRQ is -355.8%. The company is operating very inefficient. -2
  • The TTM is -355.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-355.8%TTM-355.8%0.0%
TTM-355.8%YOY-204.6%-151.2%
TTM-355.8%5Y-413,919.4%+413,563.6%
5Y-413,919.4%10Y-338,703.6%-75,215.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-355.8%-155.0%-200.8%
TTM-355.8%-266.6%-89.2%
YOY-204.6%-246.9%+42.3%
3Y-266.4%-248.8%-17.6%
5Y-413,919.4%-338.0%-413,581.4%
10Y-338,703.6%-498.1%-338,205.5%
4.3.2.2. Operating Ratio

Measures how efficient Vectus Biosystems Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.53 means that the operating costs are $4.53 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 4.529. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.529. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.529TTM4.5290.000
TTM4.529YOY3.046+1.484
TTM4.5295Y3,080.389-3,075.860
5Y3,080.38910Y2,858.209+222.180
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5291.873+2.656
TTM4.5292.793+1.736
YOY3.0462.820+0.226
3Y3.6573.575+0.082
5Y3,080.3894.664+3,075.725
10Y2,858.2096.406+2,851.803
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vectus Biosystems Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vectus Biosystems Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.93 means the company has $0.93 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 0.931. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.931. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.931TTM0.9310.000
TTM0.931YOY3.448-2.516
TTM0.9315Y2.639-1.708
5Y2.63910Y2.155+0.484
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9313.414-2.483
TTM0.9313.605-2.674
YOY3.4484.036-0.588
3Y2.8404.431-1.591
5Y2.6395.716-3.077
10Y2.1556.128-3.973
4.4.3.2. Quick Ratio

Measures if Vectus Biosystems Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.82 means the company can pay off $0.82 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 0.824. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.824. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.824TTM0.8240.000
TTM0.824YOY3.339-2.515
TTM0.8245Y2.448-1.624
5Y2.44810Y2.477-0.029
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8242.910-2.086
TTM0.8243.142-2.318
YOY3.3393.825-0.486
3Y2.7464.359-1.613
5Y2.4485.692-3.244
10Y2.4776.524-4.047
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vectus Biosystems Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Vectus Biosystems Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vectus Biosystems Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.33 means that Vectus Biosystems Ltd assets are financed with 132.8% credit (debt) and the remaining percentage (100% - 132.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 1.328. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.328. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.328TTM1.3280.000
TTM1.328YOY0.266+1.062
TTM1.3285Y1.074+0.254
5Y1.07410Y4.236-3.162
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3280.342+0.986
TTM1.3280.360+0.968
YOY0.2660.331-0.065
3Y0.6110.344+0.267
5Y1.0740.348+0.726
10Y4.2360.378+3.858
4.5.4.2. Debt to Equity Ratio

Measures if Vectus Biosystems Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vectus Biosystems Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.363-0.363
TTM-5Y0.135-0.135
5Y0.13510Y0.611-0.475
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.399-0.399
TTM-0.439-0.439
YOY0.3630.429-0.066
3Y0.2260.471-0.245
5Y0.1350.471-0.336
10Y0.6110.518+0.093
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vectus Biosystems Ltd generates.

  • Above 15 is considered overpriced but always compare Vectus Biosystems Ltd to the Biotechnology industry mean.
  • A PE ratio of -1.20 means the investor is paying $-1.20 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vectus Biosystems Ltd:

  • The EOD is -5.101. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.200. Based on the earnings, the company is expensive. -2
  • The TTM is -1.200. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.101MRQ-1.200-3.901
MRQ-1.200TTM-1.2000.000
TTM-1.200YOY-1.756+0.556
TTM-1.2005Y-7.945+6.745
5Y-7.94510Y-12.369+4.424
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.101-2.850-2.251
MRQ-1.200-2.296+1.096
TTM-1.200-2.701+1.501
YOY-1.756-3.622+1.866
3Y-3.254-3.843+0.589
5Y-7.945-6.007-1.938
10Y-12.369-6.977-5.392
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vectus Biosystems Ltd:

  • The EOD is -10.923. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.570. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.570. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.923MRQ-2.570-8.353
MRQ-2.570TTM-2.5700.000
TTM-2.570YOY-1.955-0.615
TTM-2.5705Y-9.663+7.093
5Y-9.66310Y-15.714+6.051
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.923-3.583-7.340
MRQ-2.570-2.921+0.351
TTM-2.570-3.869+1.299
YOY-1.955-4.296+2.341
3Y-4.809-5.305+0.496
5Y-9.663-8.442-1.221
10Y-15.714-9.974-5.740
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Vectus Biosystems Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -8.31 means the investor is paying $-8.31 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vectus Biosystems Ltd:

  • The EOD is -35.331. Based on the equity, the company is expensive. -2
  • The MRQ is -8.313. Based on the equity, the company is expensive. -2
  • The TTM is -8.313. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-35.331MRQ-8.313-27.018
MRQ-8.313TTM-8.3130.000
TTM-8.313YOY2.763-11.076
TTM-8.3135Y-7.121-1.192
5Y-7.12110Y59.364-66.485
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-35.3312.506-37.837
MRQ-8.3132.062-10.375
TTM-8.3132.248-10.561
YOY2.7632.465+0.298
3Y0.3702.704-2.334
5Y-7.1213.833-10.954
10Y59.3644.581+54.783
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vectus Biosystems Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. All numbers in thousands.

Summary
Total Assets783
Total Liabilities1,039
Total Stockholder Equity-257
 As reported
Total Liabilities 1,039
Total Stockholder Equity+ -257
Total Assets = 783

Assets

Total Assets783
Total Current Assets778
Long-term Assets4
Total Current Assets
Cash And Cash Equivalents 251
Net Receivables 438
Inventory 1
Other Current Assets 89
Total Current Assets  (as reported)778
Total Current Assets  (calculated)778
+/-0
Long-term Assets
Property Plant Equipment 4
Long-term Assets  (as reported)4
Long-term Assets  (calculated)4
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities836
Long-term Liabilities203
Total Stockholder Equity-257
Total Current Liabilities
Accounts payable 534
Other Current Liabilities 302
Total Current Liabilities  (as reported)836
Total Current Liabilities  (calculated)836
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)203
Long-term Liabilities  (calculated)0
+/- 203
Total Stockholder Equity
Common Stock38,369
Retained Earnings -39,503
Accumulated Other Comprehensive Income 878
Total Stockholder Equity (as reported)-257
Total Stockholder Equity (calculated)-257
+/- 0
Other
Cash and Short Term Investments 251
Common Stock Shares Outstanding 53,250
Liabilities and Stockholders Equity 783
Net Debt -51
Net Working Capital -57
Short Long Term Debt Total 200



5.2. Balance Sheets Structured

All numbers in thousands.

 Trend2025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-30
> Total Assets 
673
1,492
718
11,729
4,685
721
196
194
2,998
6,979
3,936
4,630
2,026
783
7832,0264,6303,9366,9792,9981941967214,68511,7297181,492673
   > Total Current Assets 
396
1,275
523
11,669
4,600
654
150
159
2,919
6,906
3,729
4,457
1,843
778
7781,8434,4573,7296,9062,9191591506544,60011,6695231,275396
       Cash And Cash Equivalents 
341
1,258
70
11,585
421
517
42
43
2,685
5,778
1,281
2,951
809
251
2518092,9511,2815,7782,685434251742111,585701,258341
       Short-term Investments 
0
1,161
402
34
4,034
0
0
31
31
0
0
0
0
0
000003131004,034344021,1610
       Net Receivables 
48
0
0
44
96
78
25
32
79
41
2,318
1,434
976
438
4389761,4342,318417932257896440048
       Other Current Assets 
6
2
51
34
49
137
108
84
125
1,087
129
71
57
89
8957711291,0871258410813749345126
   > Long-term Assets 
277
217
195
60
84
66
46
35
79
73
208
173
182
4
418217320873793546668460195217277
       Property Plant Equipment 
277
217
195
60
84
66
46
35
79
73
208
173
182
4
418217320873793546668460195217277
       Long-term Assets Other 
0
-217
-195
-60
0
-66
-46
-35
-79
-73
-208
-173
0
0
00-173-208-73-79-35-46-660-60-195-2170
> Total Liabilities 
1,177
516
662
511
936
604
2,453
3,924
9,709
9,878
8,358
1,106
539
1,039
1,0395391,1068,3589,8789,7093,9242,4536049365116625161,177
   > Total Current Liabilities 
463
457
590
476
904
593
2,440
1,962
1,447
1,655
7,398
1,076
535
836
8365351,0767,3981,6551,4471,9622,440593904476590457463
       Short-term Debt 
40
0
21
26
5
254
912
4
5
461
5,946
43
29
0
029435,9464615491225452621040
       Short Long Term Debt 
0
0
47
26
5
0
912
0
0
442
5,890
0
0
0
0005,8904420091205264700
       Accounts payable 
134
118
277
172
330
74
981
1,120
606
328
120
220
187
534
5341872201203286061,12098174330172277118134
       Other Current Liabilities 
268
363
292
304
541
265
530
821
805
823
1,275
814
319
302
3023198141,275823805821530265541304292363268
   > Long-term Liabilities 
714
59
73
35
32
11
13
1,958
8,261
7,210
72
30
5
203
203530727,2108,2611,958131132357359714
       Long term Debt Total 
0
0
0
0
0
0
0
1,958
7,195
7,208
70
27
0
0
0027707,2087,1951,9580000000
       Long term Debt 
700
26
26
5
0
0
0
1,958
7,160
7,191
0
0
0
0
00007,1917,1601,95800052626700
       Capital Lease Obligations 
0
0
0
0
5
0
0
8
56
35
126
70
29
0
02970126355680050000
       Other Liabilities 
15
33
46
29
32
11
13
5
0
2
72
3
0
0
0037220513113229463315
> Total Stockholder Equity
-505
976
56
11,218
3,749
117
-2,256
-3,730
-6,710
-2,899
-4,421
3,524
1,486
-257
-2571,4863,524-4,421-2,899-6,710-3,730-2,2561173,74911,21856976-505
   Common Stock
5,777
8,496
8,953
21,876
17,581
17,591
17,600
17,600
17,862
24,835
27,303
38,352
38,369
38,369
38,36938,36938,35227,30324,83517,86217,60017,60017,59117,58121,8768,9538,4965,777
   Retained Earnings -39,503-37,726-35,632-32,183-28,189-24,843-21,847-20,251-17,663-13,869-10,658-9,002-7,520-6,282
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
0
0
0
0
0
188
394
1
1,066
1,013
887
-2,720
0
0
00-2,7208871,0131,066139418800000



5.3. Balance Sheets

All numbers in thousands.




5.4. Cash Flows

All numbers in thousands.




5.5. Income Statements

All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2025-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue478
Cost of Revenue-0
Gross Profit478478
 
Operating Income (+$)
Gross Profit478
Operating Expense-2,166
Operating Income-1,688-1,688
 
Operating Expense (+$)
Research Development668
Selling General Administrative949
Selling And Marketing Expenses549
Operating Expense2,1662,166
 
Net Interest Income (+$)
Interest Income0
Interest Expense-4
Other Finance Cost-4
Net Interest Income0
 
Pretax Income (+$)
Operating Income-1,688
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,777-1,598
EBIT - interestExpense = -1,705
-2,238
-1,773
Interest Expense4
Earnings Before Interest and Taxes (EBIT)-1,701-1,773
Earnings Before Interest and Taxes (EBITDA)-1,688
 
After tax Income (+$)
Income Before Tax-1,777
Tax Provision-0
Net Income From Continuing Ops0-1,777
Net Income-1,777
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,166
Total Other Income/Expenses Net-900
 

Technical Analysis of Vectus Biosystems Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vectus Biosystems Ltd. The general trend of Vectus Biosystems Ltd is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vectus Biosystems Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Vectus Biosystems Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vectus Biosystems Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.2 < 0.2 < 0.235.

The bearish price targets are: 0.13 > 0.12 > 0.095.

Know someone who trades $VBS? Share this with them.👇

Vectus Biosystems Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vectus Biosystems Ltd. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vectus Biosystems Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vectus Biosystems Ltd. The current macd is 0.01402006.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vectus Biosystems Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vectus Biosystems Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vectus Biosystems Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vectus Biosystems Ltd Daily Moving Average Convergence/Divergence (MACD) ChartVectus Biosystems Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vectus Biosystems Ltd. The current adx is 37.68.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vectus Biosystems Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Vectus Biosystems Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vectus Biosystems Ltd. The current sar is 0.07043487.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vectus Biosystems Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vectus Biosystems Ltd. The current rsi is 96.06. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Vectus Biosystems Ltd Daily Relative Strength Index (RSI) ChartVectus Biosystems Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vectus Biosystems Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vectus Biosystems Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vectus Biosystems Ltd Daily Stochastic Oscillator ChartVectus Biosystems Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vectus Biosystems Ltd. The current cci is 361.86.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Vectus Biosystems Ltd Daily Commodity Channel Index (CCI) ChartVectus Biosystems Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vectus Biosystems Ltd. The current cmo is 97.51.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vectus Biosystems Ltd Daily Chande Momentum Oscillator (CMO) ChartVectus Biosystems Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vectus Biosystems Ltd. The current willr is -17.24137931.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Vectus Biosystems Ltd Daily Williams %R ChartVectus Biosystems Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vectus Biosystems Ltd.

Vectus Biosystems Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vectus Biosystems Ltd. The current atr is 0.01067609.

Vectus Biosystems Ltd Daily Average True Range (ATR) ChartVectus Biosystems Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vectus Biosystems Ltd. The current obv is -3,938,791.

Vectus Biosystems Ltd Daily On-Balance Volume (OBV) ChartVectus Biosystems Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vectus Biosystems Ltd. The current mfi is 95.92.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Vectus Biosystems Ltd Daily Money Flow Index (MFI) ChartVectus Biosystems Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vectus Biosystems Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-01ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-11ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-17MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-09-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-19ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-09-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-10-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Vectus Biosystems Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vectus Biosystems Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5096.059
Ma 20Greater thanMa 500.080
Ma 50Greater thanMa 1000.073
Ma 100Greater thanMa 2000.061
OpenGreater thanClose0.155
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vectus Biosystems Ltd with someone you think should read this too:
  • Are you bullish or bearish on Vectus Biosystems Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vectus Biosystems Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vectus Biosystems Ltd

I send you an email if I find something interesting about Vectus Biosystems Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Vectus Biosystems Ltd.

Receive notifications about Vectus Biosystems Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.